Consistent with the results of the western analysis, low levels of BORIS were detected in the breast cancer cell line MCF-7, whereas the increased levels of BORIS, particularly in the cytoplasm, was observed in MDA-MB-468 and MDA-MB-435 (Figure 1C, upper panel). This evidence concerns the gene CTCFL and breast carcinoma.